Quality shines through, even as M&A deal volumes fall

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Quality shines through, even as M&A deal volumes fall globally

ARLINGTON, Va., Dec. 21, 2016 (GLOBE NEWSWIRE) -- The latest Quarterly Deal Performance Monitor (QDPM) from leading global advisory, broking and solutions company Willis Towers Watson (NASDAQ: WLTW ) suggests a significant slowing of deal volumes in the fourth quarter of the year. Yet those deals that did close were high performing and showed an outperformance of 0.4 percentage points (pp) over the index. * On a year-to-date (YTD) basis, acquirers have outperformed the index by 5.4 pp.

The research — run in partnership with Cass Business School — shows deal volumes for Q4 2016 so far at 201, fewer than the 307 deals in Q4 2015, though Q4 2016 may still show strength in the final two weeks and is predicted to finish the year with an additional 40 completed deals.

“Deal volumes dropped globally, driven by the lower levels of transactions in North America and Europe,” said Mary Cianni, global M&A practice leader, Willis Towers Watson. “The results suggest that despite globally low interest rates acting as an incentive for companies to raise capital for M&A activity, the economic uncertainty post-Brexit and pre-U.S. election has caused companies to wait and see before they embark on new activity. However, the number of deals in North America suggests that, as stock markets have performed well, confidence in M&A deals has continued postelection.”

Regionally, the research reveals that North American acquirers are the most active, with a volume of 84 deals and a market performance of 4.0 pp above the regional index, but still lower than the previous quarter. Acquirers in Asia Pacific show a significant decrease in performance and are currently just above the regional index, at 0.3 pp, but have a slightly improved number of deals closing in Q4 2016 versus the previous quarter. Acquirers in Europe show an underperformance of –4.3 pp, in contrast to an outperformance of 11.6 pp above their regional index in the previous quarter.

The industry analysis shows that the Consumer Products and Services, Financial Services, Health Care, High Technology, Materials, and Telecommunications sectors are all underperforming their respective indices during the fourth quarter. However, in the overall results for YTD 2016, with the exception of Energy and Power, High Technology, and Telecommunications, all sectors have outperformed their respective indices.

“Almost all industries are showing a positive trend in performance of M&A deals this year, suggesting the days of pharma dominance in M&A activity may be long gone. M&A has become a mainstream way to look for growth and one that consistently shows higher return on investment than other growth strategies,” said Cianni.

The performance of acquirers in large, domestic, intra-regional, cross-sector and slow deals is down in Q4 2016 and is significantly lower than both Q3 2016 and Q4 2015. In a reversal of trend, mega, midsize, cross-border, cross-regional, intra-sector and quick deals have underperformed the market this quarter. Year to date, all deal types have shown an over-performance in the market.

“This quarter has seen a natural slowdown, but we need to be wary of taking one quarter’s results and forming a trend,” said Cianni. “We have entered a period of great economic uncertainty, and it is natural that organizations are being more cautious. With a three-year average of over-performance of markets by 5.8 pp, M&A remains a very attractive activity for organizations to look toward.”

Notes to editors

Acquirer outperformance compared to index * by deal type in percentage points

M&A deal type YTD 2016
Mega deals (over or equal to $10 billion) 4.5
Large deals (over or equal to $1 billion) 6.5
Midsize deals (under $1 billion) 5.1
Domestic 7.2
Cross-border 1.6
Intra-regional 6.6
Cross-regional 0.1
Intra-sector 5.0
Cross-sector 5.9

  Source: Willis Towers Watson QDPM

Acquirer outperformance by industry, adjusted to MSCI Industry Index in percentage points

Sector  YTD 2016
Materials 15.2
Industrials 3.3
High Technology –0.5
Health Care 3.9
Consumer Staples 11.0
Telecommunications –9.0
Energy and Power –0.8
Consumer Products and Services 7.8
Financial Services 8.9

Source: Willis Towers Watson QDPM

Willis Towers Watson QDPM Methodology

  • All analysis is conducted from the perspective of the acquirer.
  • Share-price performance within the quarterly study is measured as a percentage change in share price from six months prior to the announcement date to the end of the quarter.
  • All deals where the acquirer owned less than 50% of the shares of the target after the acquisition were removed, hence no minority purchases have been considered.
  • All deals where the acquirer held more than 50% of target shares prior to the acquisition have been removed, hence no remaining purchases have been considered.
  • Only completed M&A deals with a value of at least $100 million are included in this research.
  • Deal data are sourced from Thomson Reuters.

About Willis Towers Watson Human Capital M&A

Willis Towers Watson’s Human Capital M&A practice advises clients on the human capital aspects in a deal situation, ranging from key elements of a financial due diligence through to the integration of the workforce post-completion.

About Willis Towers Watson

Willis Towers Watson (NASDAQ: WLTW ) is a leading global advisory, broking and solutions company that helps clients around the world turn risk into a path for growth. With roots dating to 1828, Willis Towers Watson has 39,000 employees in more than 120 countries. We design and deliver solutions that manage risk, optimize benefits, cultivate talent, and expand the power of capital to protect and strengthen institutions and individuals. Our unique perspective allows us to see the critical intersections between talent, assets and ideas — the dynamic formula that drives business performance. Together, we unlock potential. Learn more at willistowerswatson.com.

Footnote

*MSCI World Index is used as the default.

Media contact Ed Emerman: +1 609 275-5162 eemerman@eaglepr.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Thoughts Unleashed Arrives With a Personal American Voice

Updated Category News Views 100

A lifetime of observation finally gets its own page Forty is an unusual age to begin writing poetry, which is exactly why Joyce Ann Grooms McGeehan's debut has a little more texture than the usual polished promise of inspiration. Thoughts Unleashed by an Independent, American Woman comes from someone who spent decades teaching French, English, and ESL, then retired to a...

Continue Reading
Radiate Holdco's Q3 Results: What We Know Now

Updated Category News Views 117

Digging Into Third Quarter Highlights Radiate Holdco, LLC has just thrown its third-quarter financial hat into the ring, stirring up some interest in the world of FLFO secured notes and senior notes. The folks in Princeton, N.J., sure know how to keep things exclusive—this intel is only for those holding their Notes or in the pretty exclusive club of qualified...

Continue Reading
Texas Community Bancshares Adds a Special Dividend

Updated Category News Views 65

Nine cents is the whole message—for the moment Texas Community Bancshares has put a little extra cash on the table, declaring a regular quarterly dividend of $0.06 per common share and a special cash dividend of $0.03 per share. Together, holders get $0.09 per share, payable on or about December 15, 2026, provided they are shareholders of record when business closes on...

Continue Reading
Tenax Class Action: Investors Alley Fight for Redress

Updated Category News Views 288

Tenax Therapeutics in Hot Water Over Drug Trial Results Amidst the ever-unpredictable tides of the pharmaceutical industry, here comes a doozy – Tenax Therapeutics, Inc. is neck-deep in a shareholder lawsuit. If you tossed some money at NASDAQ:TENX anytime between November 13, 2023, and August 7, 2026, you might be feeling the sting of regret, and rightly so. What Went...

Continue Reading
Epic Legal Battle Yields $63M Verdict Against Chevron

Updated Category News Views 416

A David vs. Goliath Showdown in Court How's this for a courtroom drama? Picture eight lawyers taking on Chevron over a toxic pit buried beneath an unsuspecting family's home. These folks at Ernst Law Group and Trial Lawyers for Justice tackled Union Oil (now Chevron) and bagged a staggering $63 million for their client. This ain't your run-of-the-mill legal squabble; it's...

Continue Reading
Caracal’s $200K VMI Pledge Targets Cadet Affordability

Updated Category News Views 138

A tuition award can still leave a brutal hole in the budget. That is the plain fact sitting underneath Caracal Products & Services’ $200,000 commitment to Virginia Military Institute. Federal ROTC scholarships can cover tuition, but VMI says room, board and quartermaster fees average about $15,000 annually. For a student who has done everything right—earned the ROTC...

Continue Reading
Norris Lake's New Kayak Fleet Propels Tourism Efforts

Updated Category News Views 207

Norris Lake Doubles Down on Water Adventures The winds of change are paddling through Norris Dam State Park as they've launched a new fleet of shiny kayaks, hoping to lure more adventure seekers into the heart of Tennessee. These ain't just boats; they're part of a bigger play by local tourism honchos hungry to pump some adrenaline—and dollars—back into the area. A...

Continue Reading
Knotch Bets Brands Need Answers, Not More Web Pages

Updated Category News Views 102

Pages are starting to look like expensive filing cabinets A website that cannot answer an agent may soon be expensive wallpaper. That is the blunt premise behind Knotch's Ace for Agents, launched Nov. 17, 2026, and frankly it lands because plenty of big companies have spent years piling pages atop pages until nobody can tell which claim is current. Knotch is pitching an...

Continue Reading
Rakuten Medical Fires Up Phase 1 Trial for RM-0256 Therapy

Updated Category News Views 310

Taking Aim at Refractory Tumors in Japan Get this—Rakuten Medical is stepping into the ring with their new cancer-busting tactic, RM-0256 photoimmunotherapy, right in Japan. We're talking about a Phase 1 trial that'll throw a new kind of punch at solid tumors, specifically targeting troublesome skin cancers that don’t seem to play nice with current treatments. Now,...

Continue Reading
Kobo and CloudLibrary Make Library Ebooks Much Easier

Updated Category News Views 38

A tiny button can change whether a digital service gets used Borrowing an ebook ought not feel like assembling a radio in a dark garage, yet that is roughly where library reading has landed for plenty of people. OCLC's new CloudLibrary integration with Kobo strips out a particularly annoying step: U.S. and Canadian users can link accounts once, borrow a title, and have it...

Continue Reading

Top 5 Most Recently Viewed Articles

AXIA Time Honors Ohio State's Title with Unique Watch Sets

Updated Category News Views 254

Introducing AXIA Time's Exclusive Collection AXIA Time, the official timepiece of prominent college football events, is excited to unveil a special collaboration with Ryan Day. This partnership marks a notable celebration for Ohio State University's recent achievements, delivering unique limited-edition items that honor the history of its football program. Limited Edition...

Continue Reading
AstraZeneca's Historic NYSE Move Signals Market Shift

Updated Category News Views 53

AstraZeneca's Gigantic Leap In the hustle of Wall Street's whirring machine, June 5, 2026, dawned with a palpable buzz. Why? AstraZeneca (NYSE:AZN) just pulled off the biggest market cap transfer in the New York Stock Exchange's epic 234-year saga. Now that's a splash, not just a ripple. It’s like watching a giant whale breach in an already crowded ocean. But what does...

Continue Reading
Dr. Gunther von Hagens: A Legacy of Human Anatomy

Updated Category News Views 112

A Groundbreaking Visionary in Anatomy Passes The world has lost a pioneer in anatomical science. Dr. Gunther von Hagens, inventor of the groundbreaking technique known as Plastination and creator of the BODY WORLDS exhibitions, passed away on July 24, 2026, at the age of 81. His innovative work fundamentally changed the way we view and understand human anatomy. Not quite...

Continue Reading
Exploring the Future of Yachting: Insights from Monaco's Symposium

Updated Category News Views 138

Reviving Ambitions at the Yacht Club de Monaco The Yacht Club de Monaco recently held a significant event, the 17th Business Symposium – La Belle Classe Superyachts, in collaboration with UBS. This prestigious dinner debate has evolved into more than just a gathering; it has transformed into a critical platform where influential figures in the yachting industry share...

Continue Reading
Marex Group Plc Set to Release Q3 2024 Earnings Soon

Updated Category News Views 51

Marex Group Plc Set to Release Q3 2024 Earnings Soon Marex Group plc (NASDAQ: MRX) has officially announced that it will be unveiling its third quarter results for the fiscal year 2024. This significant event is scheduled to take place before the market opens on an upcoming Thursday in November. Investors and analysts are eagerly anticipating this release, which will...

Continue Reading